<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05792020</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00124327</org_study_id>
    <nct_id>NCT05792020</nct_id>
  </id_info>
  <brief_title>Safety, Parameterization, and Mechanism of Transcranial Focused Ultrasound</brief_title>
  <official_title>Safety, Parameterization, and Mechanism of Transcranial Focused Ultrasound (fUS) Over the Motor Cortex</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BRAINBox Solutions Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Through the BrainBox Initiative, we propose to study the effects of motor tFUS on Motor&#xD;
      Evoked Potentials (MEPs) and GABA and Glutamate Concentrations in the Brain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      tFUS is an emerging neuromodulatory tool that uses pulses of low-intensity acoustic waves to&#xD;
      stimulate deep brain structures such as the thalamus. tFUS has recently been used to probe&#xD;
      deep brain structures in unresponsive wakefulness, pain, anxiety, and other neuropsychiatric&#xD;
      conditions. However, tFUS is restricted mainly by use in the MR scanner environment, thus&#xD;
      limiting session numbers by scan cost and participant comfort. Furthermore, with few human&#xD;
      studies to date, the parameter space and mechanisms of action warrant further elucidation.&#xD;
      Using novel focused ultrasound methods, we can stimulate at a minimum penetration distance of&#xD;
      20mm, uniquely enabling the study of the neuromodulatory effects of tFUS on cortical tissue.&#xD;
      Specifically, we propose to study the effects of motor tFUS on motor-evoked potentials (MEPs)&#xD;
      and GABA concentration. The proposed research is critical for understanding tFUS and&#xD;
      advancing its therapeutic potential for future clinical trials.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 15, 2023</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Within-subject, each participant will receive one excitatory course of stimulation and one inhibitory course of stimulation of the motor cortex.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Device stimulation will be blinded by the outcomes assessor to maintain the blinding of the participants and care provider</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Motor Evoked Potential Amplitude</measure>
    <time_frame>Immediate Post-Stimulation</time_frame>
    <description>How has the focused ultrasound stimulation affected MEP amplitude</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Excitatory tFUS parameters effect on Motor Evoked Potentials</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will receive three sessions of Focused Ultrasound Stimulation to their motor hotspot. This stimulation cycle will operate at a 50% duty cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inhibitory tFUS parameters effect of Motor Evoked Potentials</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will receive three sessions of Focused Ultrasound Stimulation to their motor hotspot. This stimulation cycle will operate at a 5% duty cycle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tFUS parameters effect of Motor Evoked Potentials</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>All participants will receive three sessions of Focused Ultrasound Stimulation to their motor hotspot. This stimulation cycle will utilize an air-filled spacer to block stimulation from reaching the brain</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Focused Ultrasound Stimulation</intervention_name>
    <description>This aim will test whether motor tFUS parameters thought to be excitatory (50% duty cycle) vs. inhibitory (5% duty cycle) elicit their predicted effects on MEPs before and after each of three stimulation blocks, using 50 MEPs at each time point.</description>
    <arm_group_label>Excitatory tFUS parameters effect on Motor Evoked Potentials</arm_group_label>
    <arm_group_label>Inhibitory tFUS parameters effect of Motor Evoked Potentials</arm_group_label>
    <arm_group_label>Sham tFUS parameters effect of Motor Evoked Potentials</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  Age 18-55&#xD;
&#xD;
          -  Endorse good health with no history of mental or physical illness or implanted metal&#xD;
&#xD;
          -  English as a primary language&#xD;
&#xD;
          -  Capacity to consent&#xD;
&#xD;
          -  Negative urine pregnancy test if a female of childbearing potential&#xD;
&#xD;
          -  Willingness to adhere to the tFUS and MRI study schedule&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any psychotropic medication is taken within 5 half-lives of procedure time&#xD;
&#xD;
          -  Any head trauma resulting in loss of consciousness&#xD;
&#xD;
          -  Personal or family history of neurological illness or injury&#xD;
&#xD;
          -  Alcohol or substance abuse or dependence (other than tobacco) in the past week&#xD;
&#xD;
          -  Diagnosis or current treatment (pharmacological or otherwise) of any psychiatric&#xD;
             condition&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Personal or family history of seizures or epilepsy&#xD;
&#xD;
          -  Claustrophobia or inability to stay still in the MR scanner environment&#xD;
&#xD;
          -  Any metal in the body&#xD;
&#xD;
          -  Other contraindications to electrical or electromagnetic stimulation&#xD;
&#xD;
          -  Hair in dreadlocks, braids, or weave&#xD;
&#xD;
          -  Diagnosis of COVID-19 in the past 14 days&#xD;
&#xD;
          -  Inability to adhere to the treatment schedule.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lisa M McTeague, Ph.D.</last_name>
    <phone>8437928274</phone>
    <email>mcteague@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kevin A Caulfield</last_name>
    <email>caulfiel@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Lisa M McTeague, PhD</last_name>
      <phone>843-792-8274</phone>
      <email>mcteague@musc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Allison K Wilkerson, PhD</last_name>
      <phone>843-792-4636</phone>
      <email>wilkersa@musc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 17, 2023</study_first_submitted>
  <study_first_submitted_qc>March 17, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2023</study_first_posted>
  <last_update_submitted>March 17, 2023</last_update_submitted>
  <last_update_submitted_qc>March 17, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Kevin Caulfield</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Transcranial Focused Ultrasound</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

